PerkinElmer realigns business for strategic focus
This article was originally published in Clinica
Life sciences group PerkinElmer is set to re-organise its business operations into two segments – human health and environmental health – in order to make its strategic mission clearer and improve its communication. As of January 1 2009, the company’s human health business will specialise in developing diagnostics, tools and applications to fight illness, provide better medical insight, and create new therapies. This unit will incorporate Waltham, Massachusetts-based PerkinElmer’s genetic screening, bio-discovery and medical imaging operations and will be led by the firm’s president and CEO Robert Friel on an interim basis. The environmental health side of the business will house the company’s analytical sciences, laboratory services and detection and illumination units and will be headed by John Roush, who is currently head of its optoelectronics arm.